Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 3, 2005

View Archived Issues

CPU-86017 enhances BBB permeability as a result of oxidative stress

Depomed and Esprit Pharma enter Proquin XR marketing agreement

MRX-3 improves asthma symptoms in animal studies

First stage of phase II MetXia study completed

Aegis signs new deal for Intravail technology

Phogen and Cancer Research Technology sign agreement for VP22 technology

Harvard and Crucell receive NIH grant for next-generation AdVac vaccines for HIV/AIDS

CE Mark approval for Endeavor drug-eluting stent

WX-671 successfully completes first phase I study

Indevus inlicenses Nebido U.S. rights

Curcumin demonstrates antidepressant-like effects

HX-531 pretreatment improves responses to leptin

In vitro data presented on novel VCAM-1 inhibitor from Novartis

Novel inhibitors of anthrax lethal factor demonstrate significant protection in vivo

Procaine protects against beta-amyloid neurotoxicity in vitro

Orphan drug designation for Large Scale Biology's lysosomal acid lipase

Celebrex approved for ankylosing spondylitis

Japanese approval for Cleactor for acute pulmonary embolism

Final phase I data on the effects and safety of Proellex in uterine fibroids

Therapeutic agents for respiratory and inflammatory disorders in early development

Sevelamer decreases mortality and morbidity of hemodialysis patients

CR-665 shows a promising safety and pharmacokinetic profile in healthy subjects

Novel agents disclosed for the treatment of diabetes and related disorders

Dompe patent claims novel chemokine CXCR1/CXCR2 receptor antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...